Activation of the NOTCH1 pathway in chronic lymphocytic leukemia
- PMID: 22383743
- PMCID: PMC3291584
- DOI: 10.3324/haematol.2012.061721
Activation of the NOTCH1 pathway in chronic lymphocytic leukemia
Figures

Comment on
-
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.Haematologica. 2012 Mar;97(3):437-41. doi: 10.3324/haematol.2011.060129. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207691 Free PMC article.
Similar articles
-
NOTCH1 mutations in chronic lymphocytic leukemia with trisomy 12.Genes Chromosomes Cancer. 2012 Nov;51(11):1063; author reply 1064-5. doi: 10.1002/gcc.21987. Epub 2012 Jul 25. Genes Chromosomes Cancer. 2012. PMID: 22833497 No abstract available.
-
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.Haematologica. 2012 Mar;97(3):437-41. doi: 10.3324/haematol.2011.060129. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207691 Free PMC article.
-
Trisomy 12 CLLs progress through NOTCH1 mutations.Leukemia. 2013 Mar;27(3):740-3. doi: 10.1038/leu.2012.239. Epub 2012 Aug 20. Leukemia. 2013. PMID: 22902365 Free PMC article. No abstract available.
-
Trisomy 12 in CLL revisited.Leuk Res. 1997 Nov-Dec;21(11-12):1025-6. doi: 10.1016/s0145-2126(97)80879-x. Leuk Res. 1997. PMID: 9444934 Review. No abstract available.
-
Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.J Med Case Rep. 2018 Mar 11;12(1):64. doi: 10.1186/s13256-018-1612-4. J Med Case Rep. 2018. PMID: 29524963 Free PMC article. Review.
Cited by
-
Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.Med Oncol. 2015 Feb;32(2):479. doi: 10.1007/s12032-014-0479-5. Epub 2015 Jan 10. Med Oncol. 2015. PMID: 25575438
-
NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia.Oncol Lett. 2019 Apr;17(4):4016-4023. doi: 10.3892/ol.2019.10048. Epub 2019 Feb 19. Oncol Lett. 2019. PMID: 30930998 Free PMC article.
-
Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3245-3250. doi: 10.22034/APJCP.2017.18.12.3245. Asian Pac J Cancer Prev. 2017. PMID: 29286214 Free PMC article.
-
Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infections in chronic lymphocytic leukemia patients.Rev Bras Hematol Hemoter. 2014;36(1):29-34. doi: 10.5581/1516-8484.20140010. Rev Bras Hematol Hemoter. 2014. PMID: 24624033 Free PMC article.
-
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia.PPAR Res. 2023 Jun 26;2023:8456833. doi: 10.1155/2023/8456833. eCollection 2023. PPAR Res. 2023. PMID: 37404899 Free PMC article.
References
-
- Di Ianni M, Baldoni S, Rosati E, Ciurnelli R, Cavalli L, Martelli MF, et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br J Haematol. 2009;146(6):689–91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources